Preparation of aromatic carboxamides via palladium-catalyzed carbonylation

By performing the carbonylation reaction of palladium-catalyzed aromatic chloride and amine under low pressure and low catalyst concentration conditions, the problems of high catalyst loading and post-treatment complexity in the prior art are solved, and efficient and economical aromatics are achieved Carboxylamide preparation.

CN115298163BActive Publication Date: 2024-11-19BASF SE
View PDF 24 Cites 0 Cited by

Patent Information

Application Number
CN202180021711.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2020-04-29
Filing Date
2021-04-19
Publication Date
2024-11-19
Estimated Expiration
2041-04-19

AI Technical Summary

Technical Problem

In the preparation of aromatic carboxamides, high catalyst loading leads to increased economic costs and difficult industrial application, and there are undesired catalyst precipitation and complex post-processing procedures under high catalyst concentrations.

Method used

Using a palladium catalyst system with low pressure reaction conditions (less than 20 bar) and low catalyst concentration (<0.5 mole%), the palladium-based catalysts and phosphine ligands are used to carbonylation reactions of aromatic chlorides, amines and carbon monoxide in the presence of alkali. The combination of the aromatic carboxamides can be achieved efficiently, and the stability and conversion rate of the catalyst are improved by optimizing the reaction conditions and selecting suitable bases and solvents.

Benefits of technology

It realizes efficient and economical preparation of aromatic carboxylamides on industrial scale, reduces the amount of catalyst used and post-treatment complexity, improves the stability and conversion rate of the catalyst, and reduces the demand for carbon monoxide pressure.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115298163B_ABST
    Figure CN115298163B_ABST
Patent Text Reader

Abstract

The present invention relates to a process for preparing aromatic carboxamides of formula I, which can be obtained by palladium-catalyzed carbonylation of aromatic chlorides of formula II, amines of formula III and carbon monoxide in the presence of a base. The present invention further relates to a process for preparing aryl-5-trifluoromethyl-1,2,4-#imgabs0#oxadiazoles, which are known for controlling plant pathogenic fungi. #imgabs1#
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention relates to a method for preparing an aromatic carboxamide of formula I, which can be obtained by a palladium-catalyzed carbonylation reaction of an aromatic chloride of formula II, an amine of formula III and carbon monoxide in the presence of a base. The present invention further relates to a method for preparing an aromatic 5-trifluoromethyl-1,2,4- The method of using oxadiazoles, which have been described in the prior art for controlling phytopathogenic fungi, for example in WO 2015 / 185485 or WO 2017 / 211649.

[0002]

[0003] The carbonylation reaction for the preparation of the aromatic carboxamides of formula I is known in the prior art. These conversions are transition metal catalyzed processes which produce carboxamides in one step by aryl halides, carbon monoxide and amines. This procedure can quickly obtain diversified structural units. In these reactions, a base must be added to neutralize the hydrogen halide released in the reaction.

[0004] Heck et al. first reported this type of palladium-catalyzed procedure in Journal of Organic Chemistry 1974, 39, 3318 (and patents US 3988358 and US 4128554). Since then, many variations of this reaction type have been described in the literature.

[0005] Economic interest is mainly focused on the use of aromatic chlorides because they are both cheap and readily available. However, their relative chemical inertness makes them more challenging substrates in palladium-catalyzed carbonylation reactions, which can be said to be the main reason why most reported reactions use more reactive aromatic bromides, iodides or trifluoromethylsulfonates. Batch reactions with aromatic chlorides usually require the presence of 2 mol % or more of catalyst to fully convert the aromatic chloride. However, at such high catalyst loadings, conversion to industrial-scale applications is economically prohibitive in many cases. High catalyst concentrations can also lead to unwanted catalyst precipitation under reaction conditions.

[0006] Perry et al. reported that the conversion of aromatic chlorides in aminocarbonylation reactions (at constant catalyst concentration) was increased by the addition of halides, particularly sodium iodide (Journal of Organic Chemistry 1996, 61, 7482-7485 and US 5672750). The reaction of aromatic chlorides, carbon monoxide (5 psig or 0.34 bar (34 kPa)), 3 mol% palladium catalyst and 6 mol% bidentate phosphine ligands, 1.2 equivalents of 1,8-diazabicyclo-[5.4.0]undec-7-ene (DBU) and at least 1 equivalent of sodium iodide at 115°C provided carboxamides in good yields compared to the same reaction without sodium iodide, which produced only a small amount of carboxamide. The disadvantage of this method is that the use of halides generates additional costs, complicates the post-processing procedures and often leads to corrosion of the reactor.

[0007] Buchwald et al. (Angew. Chem. Int. Ed. 2007, 46, 8460-8463) describe the influence of base in palladium-catalyzed aminocarbonylation of aromatic chlorides at atmospheric pressure. The procedure uses 2 mol % of palladium catalyst, bidentate phosphine ligand and 2 equivalents of base at 120°C. The best yield is obtained with sodium phenolate as base. The use of DBU leads to relatively low conversion of aromatic chlorides and poor yield of carboxamide.

[0008] WO 2009 / 144197 A1 discloses a method for producing aromatic and heteroaromatic carboxylic acids, carboxylic esters and carboxylic acid amides (carboxamides). Reference is made to preparing carboxamides from aniline and aromatic chlorides at 130-150° C. and 15 bar (1500 kPa) in the presence of a palladium catalyst and 1.5 equivalents of a base, such as DBU, triethylamine and potassium carbonate (operating examples 6-1 to 6-3). Carboxamides are obtained in low to moderate yields.

[0009] An object of the present invention is to overcome the disadvantages of the known processes and to provide an improved and more economical and production plant friendly process which enables the preparation of aromatic carboxamides on an industrial scale, with an emphasis on low pressure reactions (less than 20 bar (2000 kPa)), wherein the catalyst is sufficiently efficient to allow operation at low catalyst concentrations (i.e. <0.5 mol % catalyst loading based on the amount of aromatic chloride), wherein the catalyst turnover is sufficiently stable that complete conversion can be achieved within a reasonable time. It is known that improved catalyst stability means lower catalyst loadings, which are required for efficient conversion of aromatic chlorides.

[0010] The inventors have surprisingly found that the method of the present invention provides solutions to these problems. The method of the present invention is cost-effective because it allows the use of palladium catalysts of significantly lower amounts than previously reported procedures. The method of the present invention can use cheap alkalis, therefore providing further advantages in industrial settings. In addition, the method of the present invention does not require excessively high carbon monoxide pressures.

[0011] Accordingly, the present invention relates to a process for preparing a compound of formula I,

[0012]

[0013] in

[0014] Aryl is phenyl or a 5- or 6-membered aromatic heterocycle; wherein the aromatic heterocycle has, in addition to carbon atoms, 1, 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms, provided that the heterocycle cannot contain 2 adjacent atoms selected from O and S; wherein Aryl is further unsubstituted or further substituted by n additional identical or different groups R A Replace;

[0015] n is 0, 1, 2, 3 or 4;

[0016] R A R is independently selected from fluorine, chlorine, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, -S(=O)2-CH3, -OC≡N, -SC≡N, -N=C=O, -N=C=S, di-C1-C6-alkylamino, -C(=O)-C1-C6-alkyl, -C(=O)-O-C1-C6-alkyl and -CH2OH; 1 It is C1-C6-alkyl, C1-C6-alkoxy, C3-C 11-cycloalkyl, C3-C8-cycloalkenyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkoxyimino-C1-C4-alkyl, C2-C6-alkenyloxyimino-C1-C4-alkyl, C2-C6-alkynyloxyimino-C1-C4-alkyl, C1-C6-alkylamino, di-C1-C6-alkylamino, -C(=O)-C1-C6-alkyl, -C(=O)-O-C1-C6-alkyl, -C(=O)-N(C1-C6-alkyl)2, phenyl-C1-C4-alkyl, phenyl-C1-C4-alkenyl, phenyl-C1-C4-alkynyl, heteroaryl-C1-C4-alkyl, phenyl, naphthyl or 3- to 10-membered saturated, partially an aromatic monocyclic or bicyclic heterocycle, wherein the ring members of the monocyclic or bicyclic heterocycle include, in addition to carbon atoms, 1, 2, 3 or 4 heteroatoms selected from N, O and S as ring members, provided that the heterocycle cannot contain 2 adjacent atoms selected from O and S; wherein the heteroaryl radical in the group heteroaryl-C1-C4-alkyl is a 5- or 6-membered aromatic heterocycle, wherein the ring members of the heterocyclic ring include, in addition to carbon atoms, 1, 2, 3 or 4 heteroatoms selected from N, O and S as ring members, provided that the heterocycle cannot contain 2 adjacent atoms selected from O and S; wherein any of the abovementioned aliphatic or cyclic radicals is unsubstituted or replaced by 1, 2, 3 or up to the maximum possible number of identical or different radicals R 1a Replacement; or R 1 and R 2 , together with the nitrogen atom to which they are attached, form a saturated or partially unsaturated monocyclic or bicyclic 3- to 10-membered heterocyclic ring, wherein said heterocyclic ring apart from one nitrogen atom and one or more carbon atoms comprises no further heteroatoms or comprises 1, 2 or 3 further heteroatoms independently selected from N, O and S as ring member atoms, provided that said heterocyclic ring cannot contain 2 adjacent atoms selected from O and S; wherein said heterocyclic ring is unsubstituted or replaced by 1, 2, 3, 4 or up to the maximum possible number of identical or different radicals R 1a Replace;

[0017] R 1ais halogen, oxo, cyano, NO2, OH, SH, NH2, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, C3-C8-cycloalkyl, -NHSO2-C1-C4-alkyl, -(C=O)-C1-C4-alkyl, -C(=O)-O-C1-C4-alkyl, C1-C6- Alkylsulfonyl, hydroxyC1-C4-alkyl, C(═O)—NH2, C(═O)—NH(C1-C4-alkyl), C1-C4-alkylthio-C1-C4-alkyl, aminoC1-C4-alkyl, C1-C4-alkylamino-C1-C4-alkyl, di-C1-C4-alkylamino-C1-C4-alkyl, aminocarbonyl-C1-C4-alkyl or C1-C4-alkoxy-C1-C4-alkyl;

[0018] R 2 is hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkoxy, C3-C 11 -cycloalkyl, -C(=O)-C1-C6-alkyl, -C(=O)-C3-C 11 -cycloalkyl or -C(=O)-O-C1-C6-alkyl; wherein R 2 Any aliphatic or cyclic radical in is unsubstituted or replaced by 1, 2, 3 or up to the maximum possible number of radicals selected from halogen, hydroxy, oxo, cyano, C1-C6-alkyl, C1-C6-alkoxy and C3-C 11 - substitution of cycloalkyl groups by the same or different groups;

[0019] The method comprises reacting an aromatic chloride of formula II with carbon monoxide and an amine compound of formula III

[0020] Aryl-Cl II

[0021] wherein Aryl is as defined above for compounds of formula I,

[0022]

[0023] Where R 1 and R 2 As defined above for compounds of formula I;

[0024] The reaction is carried out in the presence of a palladium-based catalyst, a solvent and a base;

[0025] The method is characterized in that the base comprises base b1 and base b2, wherein

[0026] b1 is at least one inorganic base selected from alkali metal and alkaline earth metal carbonates, bicarbonates, acetates, alkoxides, hydroxides and phosphates or mixtures thereof;

[0027] b2 is a tertiary amine base or an imine base, which is present in an amount of less than 100 mol %, based on the amount of the compound of formula II.

[0028] The carbonylation reaction of the present invention is carried out in the presence of a palladium-based catalyst selected from at least one Pd(II) compound or Pd(0) compound or a complex obtained by complexing a Pd(II) compound or Pd(0) compound with a ligand, particularly a phosphine ligand. The palladium-based catalyst can be used as a preformed complex or can be combined in situ by combining a palladium compound and a ligand or a salt thereof.

[0029] Suitable palladium compounds or complexes are, for example, palladium(II) acetate, palladium(II) chloride, palladium(II) bromide, palladium(II) nitrate, palladium(II) acetylacetonate, palladium(0)-dibenzylideneacetone complex, palladium(0)-tetrakis(triphenylphosphine), palladium(0)-bis(tri-o-tolylphosphine), palladium(0)(DPEphos)dicarbonyl, palladium(II) propionate, palladium(II)-bis(triphenylphosphine) dichloride, palladium(II)-(bis(diphenylphosphino)ferrocene) dichloride, palladium(II) nitrate, palladium(II)-bis(acetonitrile) dichloride, palladium(II)-bis(benzonitrile) dichloride, palladium(II) hydroxide, palladium(0), [palladium(allyl)Cl]2, palladium(0) on carbon (Pd / C) and palladium(II)-bis(benzonitrile)-dichloride.

[0030] The carbonylation reaction is preferably carried out in the presence of a suitable Pd(II) compound or Pd(0) compound complexed with a ligand, in particular a monodentate or bidentate phosphine ligand.

[0031] Examples of preferred monodentate phosphines are trialkylphosphines, triarylphosphines, dialkylarylphosphines, alkyldiarylphosphines, cycloalkyldiarylphosphines, dicycloalkylarylphosphines and tricycloalkylphosphines. Other examples of preferred phosphines are triheterocyclic phosphines and triheteroarylphosphines. Examples of preferred trialkylphosphines are triethylphosphine, tri-n-butylphosphine, tri-tert-butylphosphine, triisopropylphosphine, tribenzylphosphine. Examples of preferred tricycloalkylphosphines are tri(cyclopentyl)phosphine, tri(cyclohexyl)phosphine. Examples of preferred triarylphosphines are triphenylphosphine, tri(p-tolyl)phosphine, tri(m-tolyl)phosphine, tri(o-tolyl)phosphine, tri(p-methoxyphenyl)phosphine, tri(p-dimethylaminophenyl)phosphine, tri(sodium-m-phenylsulfonate)-phosphine, diphenyl(2-phenylsulfonate)phosphine, tri(1-naphthyl)phosphine and diphenyl-2-pyridylphosphine. Examples of preferred dialkylaryl phosphines are dimethylphenylphosphine and di-tert-butylphenylphosphine.

[0032] Examples of preferred alkyl diaryl phosphines are ethyl diphenyl phosphine and isopropyl diphenyl phosphine. An example of a preferred cycloalkyl diaryl phosphine is cyclohexyl diphenyl phosphine. An example of a preferred dicycloalkyl aryl phosphine is dicyclohexyl phenyl phosphine. Further examples of preferred triaryl phosphines are tri(o-methoxyphenyl)phosphine, tri(m-methoxyphenyl)phosphine, tri(p-fluorophenyl)phosphine, tri(m-fluorophenyl)phosphine, tri(o-fluorophenyl)phosphine, tri(p-chlorophenyl)phosphine, tri(m-chlorophenyl)phosphine, tri(pentafluorophenyl)-phosphine, tri(p-trifluoromethylphenyl)phosphine, tri[3,5-bis(trifluoromethyl)phenyl]-phosphine, diphenyl(o-methoxyphenyl)phosphine, diphenyl(o-methylphenyl)phosphine, tri(3,5-dimethylphenyl)phosphine and tri-2-naphthylphosphine. An example of a preferred triheteroaryl phosphine is tri(o-furyl)phosphine. An example of a preferred trialkyl phosphine is triisobutylphosphine. An example of a preferred triheterocyclic phosphine is tri(1-pyrrolidinyl)phosphine. Particularly preferred are triphenylphosphine, di-tert-butylphenylphosphine, cyclohexyldiphenylphosphine, dicyclohexylphenylphosphine, tri(p-tolyl)phosphine and tri(cyclohexyl)phosphine.

[0033] Suitable bidentate phosphine ligands are 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (BINAP), 2-bis(diphenylphosphino)ethane (DPPE), 1,3-bis(diphenylphosphino)-propane (DPPP), 1,4-bis(diphenylphosphino)butane (DPPB), 1,1'-bis(diphenylphosphino)ferrocene (DPPF), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (Xanthenyl) os), bis(2-diphenylphosphino)phenyl]ether (DPEphos), 1,2-bis(di-tert-butylphosphinomethyl)benzene, 1,2-bis(di-tert-amylphosphinomethyl)-benzene, 1,2-bis(di-tert-butylphosphinomethyl)naphthalene, 2,2-dimethyl-1,3-bis(diphenylphosphino)-propane, 1,3-bis(diisopropylphosphino)-propane (DiPrPP), 1,3-bis(tert-butylphosphino)-propane (DtBuP P), 1,3-bis(n-butylphosphino)-propane (DnBuPP), 1,3-bis(diisopropylphosphino)-ethane (DCPE), 1,3-bis(dicyclohexylphosphino)-butane (DCPB), (1R)-1-[bis(1,1-dimethylethyl)phosphino]-2-[(1R)-1-[bis(2-methylphenyl)phosphino]ethyl]ferrocene, (2R)-1-[(1R)-1-[bis(1,1-dimethylethyl)phosphino]-2-[(1R)-1-[bis(2-methylphenyl)phosphino]ethyl]ferrocene, 1-(dicyclohexylphosphino)ethyl]-2-(diphenylphosphino)ferrocene, (2R)-1-[(1R)-1-(dicyclohexylphosphino)ethyl]-2-(diphenylphosphino)ferrocene, (1R)-1-(dicyclohexylphosphino)-2-[(1R)-1-(dicyclohexylphosphino)ethyl]ferrocene, 2-ethyl-2-butyl-1,3-bis(diphenylphosphino)-propane and 1,3-bis(dicyclohexylphosphino)-propane (DCPP).

[0034] In a preferred embodiment, the carbonylation reaction is carried out in the presence of a bidentate phosphine ligand; in particular DCPP.

[0035] Complexes with monodentate ligands of the type L2Pd(II)X2 or Pd(0)L4 (X = anionic ligand; L = electrically neutral phosphine ligand) are also suitable in the carbonylation reaction of the present invention, for example (tri(cyclohexyl)phosphine)2Pd(II)Cl2 or Pd(0)(triphenylphosphine)4. Complexes with bidentate ligands of the type LPd(II)X2, Pd(0)L2 or Pd(0)L2(CO)2 are also suitable, for example (DCPP)Pd(II)Cl2 or (DCPE)Pd(II)Cl2. Many ligands can also be supplied as salts, which can also be used in combination with palladium compounds in the present invention, for example P(tert-Bu)3*HBF4 or DCPP*2HBF4.

[0036] In one aspect, the carbonylation reaction is carried out in the presence of a free phosphine, which means that the phosphine is used in excess so that a portion of it is not bound in the palladium complex. The molar ratio of phosphine ligand to palladium is generally between 0.5:1 and 10:1, preferably between 0.5:1 and 5:1.

[0037] The palladium catalyst is used in an amount of less than 2 mol%, or less than 1 mol%, or less than 0.5 mol%, preferably between 0.001 and 0.3 mol%, more preferably between 0.001 and 0.2 mol%, based on the amount of the aromatic chloride of formula II.

[0038] Under the reaction conditions of the present invention, the Pd catalyst can undergo a ligand exchange reaction so that the anionic ligand X and / or the neutral ligand L is replaced by other ligands present in the reaction mixture, such as CO, amines or even a portion of the substrate molecule (which can form a large number of complexes after elementary reactions such as oxidative addition, or aryl halides).

[0039] The palladium catalyst can be used as a homogeneous solution in the reaction medium, or it can be formed from a heterogeneous catalyst precursor, such as colloidal Pd(0), Pd(0) applied to a support material, or a Pd(II) compound applied to a support material, such as Pd(0) or a Pd(II) salt. Suitable support materials are, for example, inorganic metal oxides, silicates and carbon.

[0040] The palladium catalyst may be removed from the reaction mixture using conventional work-up procedures known to the skilled artisan and, after isolation, may be reused in carbonylation reactions of the type described herein.

[0041] After the reaction is carried out, the Pd catalyst can be reused. To achieve this, the chloride salt can be removed from the resulting reaction mixture by filtration, the solvent can then be removed by distillation, and the product can then be isolated by filtration or distillation. The remaining residue contains most of the palladium catalyst, which can be reused for subsequent aminocarbonylation reactions. All operations must be carried out in a manner that does not affect the performance of the catalyst, i.e., must be operated under an inert atmosphere.

[0042] The carbonylation reaction according to the invention is carried out in the presence of carbon monoxide. This means that the reaction is carried out with pure carbon monoxide or with a mixture of carbon monoxide and an inert gas, for example nitrogen or a noble gas (helium, neon, argon). The carbonylation is usually carried out in a reaction vessel at atmospheric pressure or under elevated pressure. The term "elevated pressure" in the present invention refers to a pressure above 1 bar (100 kPa). Suitable reaction vessels or reactors are known to the person skilled in the art, for example from "Ullmanns der technischen Chemie, Vol. 1, 3rd edition, 1951, pages 769 et seq.

[0043] The carbon monoxide partial pressure in the carbonylation according to the invention is less than 100 bar (10000 kPa), preferably less than 50 bar (5000 kPa), more preferably less than 20 bar (2000 kPa), in a particularly preferred aspect, less than 15 bar (1500 kPa). In a further aspect of the invention, the carbon monoxide partial pressure varies between 0.1 and 200 bar (100 and 20000 kPa), between 1 and 100 bar (100 and 10000 kPa), between 1 and 50 bar (100 and 5000 kPa), between 2 and 20 bar (200 and 2000 kPa) or between 5 and 15 bar (500 and 1500 kPa).

[0044] In one embodiment, the carbonylation reaction is carried out in the absence or reduced amount of oxygen or air.

[0045] When conducted in a batch mode, the carbonylation requires a batch time of 1 hour to 100 hours, 2 hours to 50 hours, or 5 hours to 20 hours to achieve complete conversion of the aromatic chloride.

[0046] The temperature of the carbonylation reaction is suitably in the range of 20°C to 200°C; preferably in the range of 50°C to 180°C; more preferably in the range of 50°C to 150°C; especially selected in the range of 100°C to 140°C.

[0047] The carbonylation can be carried out in the dark or under illumination (typical wavelengths are in the range of 200 nm to 600 nm).

[0048] In one embodiment, the carbonylation is conducted at a temperature of from 50 to 180°C and at a carbon monoxide partial pressure of from 1 to 100 bar (100 to 5.000 kPa).

[0049] In one embodiment, the carbonylation reaction of the present invention is carried out at a temperature of 50°C to 150°C and at a carbon monoxide partial pressure of 2 to 20 bar (200 to 2000 kPa).

[0050] In one embodiment, the carbonylation reaction of the present invention is carried out at a temperature of from 100°C to 140°C and at a carbon monoxide partial pressure of from 5 to 15 bar (500 to 1500 kPa).

[0051] The carbonylation reaction of the present invention is carried out in the presence of an inert solvent. Suitable solvents are, for example, aliphatic, alicyclic and aromatic hydrocarbons (pentane, hexane, petroleum ether, cyclohexane, methylcyclohexane, benzene, toluene, xylene), aliphatic halogenated hydrocarbons (dichloromethane, chloroform, dichloroethane and tetrachloroethane), nitriles (acetonitrile, propionitrile, benzonitrile), ethers (diethyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, diethylene glycol dimethyl ether, 2-methyltetrahydrofuran, tetrahydrofuran, dioxane , diethylene glycol monomethyl ether or monoethyl ether), ketones (acetone, methyl isobutyl ketone), carboxylic acid esters and lactones (ethyl acetate and methyl acetate, valerolactone), N-substituted lactams (N-methylpyrrolidone), carboxamides (N,N-dimethylformamide, N,N-dimethylacetamide), acyclic ureas (dimethylimidazolinium), nitriles (such as acetonitrile or propionitrile) and sulfoxides and sulfones (dimethyl sulfoxide, dimethyl sulfone, tetramethylene sulfoxide, cyclopentane).

[0052] Preferred solvents are generally polar organic solvents such as tetrahydrofuran, dimethylformamide, N-methylpyrrolidone, dioxane, 2-methyltetrahydrofuran, N,N-dimethylacetamide, toluene, acetonitrile.

[0053] The carbonylation reaction of the present invention is carried out in the presence of an inorganic base b1 to neutralize the hydrogen chloride provided during the reaction.

[0054] Examples of preferred inorganic bases b1 are alkali metal and alkaline earth metal carbonates (e.g. Na2CO 3、 K2CO3 or MgCO3), bicarbonate (such as NaHCO 3、 KHCO3 or Mg(HCO3)2), hydroxides, acetates, alkoxides, phosphates and hydrogen phosphates, which have the advantage that they are inexpensive, easy to handle, and can be easily removed by aqueous post-treatment after the carbonylation reaction is completed. Preferred alkali metal carbonates are sodium carbonate and potassium carbonate, especially potassium carbonate. Preferred alkaline earth metal carbonates are magnesium carbonate and calcium carbonate. Preferred alkali metal phosphates are sodium phosphate (Na3PO4), potassium phosphate (K3PO4) and disodium hydrogen phosphate (Na2HPO4).

[0055] In a preferred embodiment, the base b1 is an alkali metal carbonate, alkali metal phosphate, alkali metal hydrogenphosphate, alkali metal hydroxide or alkali metal acetate.

[0056] In a more preferred embodiment, the base b1 is an alkali metal carbonate or an alkali metal acetate. In a particularly preferred embodiment, the base b1 is sodium carbonate or sodium acetate.

[0057] Base b1 is used in an amount of at least 80 mol % or at least 100 mol % or at least 150 mol % based on the amount of the compound of formula II. In another aspect of the invention, base b1 is used in an amount of 80 to 1.000 mol % based on the amount of the compound of formula II. In a further aspect of the invention, base b1 is used in an amount of 80 to 500 mol % based on the amount of the compound of formula II. In yet another aspect, base b1 is used in an amount of 90 to 150 mol % based on the amount of the compound of formula II.

[0058] In a preferred embodiment of the present invention, the carbonylation reaction uses sodium carbonate or potassium carbonate as base b1 in an amount of 90 to 150 mol % based on the amount of the compound of formula II; the base b1 is especially potassium carbonate; and TBD or DBU as base b2 in an amount of 1 to 10 mol % based on the amount of the compound of formula II.

[0059] The carbonylation reaction according to the invention uses a tertiary amine base or an imine base b2 in addition to the base b1.

[0060] The term "tertiary amine base" in the context of the present invention refers to an amine compound containing at least one nitrogen atom substituted with three alkyl substituents.

[0061] The term "imine base" in the present invention refers to an amine compound containing at least one imine group "-N=".

[0062] In one embodiment, the base b2 is a tertiary amine base or an imine base selected from 1,4-diazabicyclo[2.2.2]octane (DABCO), N-methylpiperidine, lutidine, pyridine and a base of the formula B.2,

[0063]

[0064] in

[0065] X is NR 4 R 5 or C1-C4-alkyl;

[0066] R 1 , R 2 , R 3 , R 4 , R 5 independently of one another are hydrogen or C1-C4-alkyl; or

[0067] R 1 and R 2 Together with the intermediate atoms between these groups, they form a 5-, 6- or 7-membered ring containing 2 nitrogen atoms in addition to the carbon atoms;

[0068] Or, if X is NR 4 R 5 ,

[0069] R 3 and R 4 Together with the intermediate atoms between these groups, they form a 5-, 6- or 7-membered ring containing 1 or 2 nitrogen atoms in addition to carbon atoms;

[0070] Alternatively, if X is C1-C4-alkyl,

[0071] R 3 and X together with the intermediate atom between these groups form a 5-, 6- or 7-membered ring containing 1 or 2 nitrogen atoms in addition to the carbon atoms.

[0072] In another embodiment, the base b2 is an amine selected from 1,4-diazabicyclo[2.2.2]octane (DABCO), N-methylpiperidine, lutidine, pyridine and a base of the formula B.2,

[0073] in

[0074] X is NR 4 R 5 or C1-C4-alkyl;

[0075] R 1 , R 2 , R 3 , R 4 , R 5 are independently hydrogen or C1-C4-alkyl;

[0076] or

[0077] R 1 and R 2 Together with the intermediate atoms between these groups, they form a 5-, 6- or 7-membered ring containing 2 nitrogen atoms in addition to the carbon atoms;

[0078] And if X is NR 3 R 4 ,

[0079] R 3 and R 4 Together with the intermediate atoms between these groups, they form a 5-, 6- or 7-membered ring containing 1 or 2 nitrogen atoms in addition to carbon atoms;

[0080] and if X is C1-C4-alkyl,

[0081] R 3 and X together with the intermediate atom between these groups form a 5-, 6- or 7-membered ring containing 1 or 2 nitrogen atoms in addition to the carbon atoms.

[0082] In a further embodiment, base b2 is an amine selected from 1,4-diazabicyclo[2.2.2]octane (DABCO), 1,5-diazabicyclo[4.3.0]non-5-ene (DBN), 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), N-methylpiperidine, lutidine, pyridine.

[0083] In a preferred embodiment, the base b2 is DBN, TBD or DBU. In a more preferred embodiment, the base b2 is TBD or DBU; the base b2 is especially DBU.

[0084] In one aspect of the invention, alkali b2 is less than 100 mol% based on the amount of the compound of formula II, preferably less than 50 mol%, more preferably less than 10 mol%, particularly less than 5 mol% amount exists. In another aspect, alkali b2 is used in an amount of 0.1 to 50 mol% based on the amount of the compound of formula II. In yet another aspect, alkali b2 is used in an amount of 1 to 20 mol% based on the amount of the compound of formula II. In another aspect, in another aspect, alkali b2 is used in an amount of 1 to 10 mol% based on the amount of the compound of formula II. In one embodiment, alkali b2 is used in an amount of 1 to 5 mol% based on the amount of the compound of formula II.

[0085] The molar ratio of the compound of formula III to the compound of formula II is generally between 0.8:1 and 10:1, preferably between 1:1 and 5:1, more preferably between 1:1 and 2:1.

[0086] In one embodiment of the present invention, the aromatic chloride used in the carbonylation process is of the formula II.a,

[0087]

[0088] Where n is 0 or 1; A 1 and A 2 are independently selected from nitrogen, CH or CR A ; Among them A 1 and A 2 of which no more than one is nitrogen; A as defined or preferably defined herein for compounds of formula I, to obtain aromatic carboxamides of formula Ia,

[0089]

[0090] The variables n, R A , A 1 and A 2 has the meaning as defined for compound II.a, wherein the variable R 1 and R2 has the meaning as defined for the compounds of formula I.

[0091] In one embodiment of the present invention, the aromatic chloride used in the carbonylation process is of the formula II.b,

[0092]

[0093] Where n is 0 or 1, R A As defined or preferably defined herein for compounds of formula I, to obtain aromatic carboxamides of formula Ib,

[0094]

[0095] where variables n and R A has the meaning as defined for compound II.b, wherein the variable R 1 and R 2 has the meaning as defined or preferably defined herein for the compounds of formula I.

[0096] Compounds of formula II.a and II.b are either commercially available or can be prepared from readily available starting materials using standard procedures known to those skilled in the art.

[0097] In one aspect of the invention, in the compounds of formula I the variable A is phenyl.

[0098] In one embodiment of the invention, the radical R in the compounds of the formula I, Ia, Ib, II, II.a and II.b A It is fluorine, chlorine, CN, methyl, ethyl, n-propyl, isopropyl, CF3, CHF2, CH2F, -S(=O)2-CH3, -C(=O)-O-ethyl, -C(=O)-O-methyl, -C(=O)-ethyl, -C(=O)-methyl.

[0099] In one embodiment of the invention, the radical R in the compounds of the formula I, Ia, Ib, II, II.a and II.b A It is fluorine, chlorine, CN, methyl, ethyl, CF3, -S(=O)2-CH3, -C(=O)-O-ethyl, -C(=O)-O-methyl, -C(=O)-ethyl, -C(=O)-methyl.

[0100] In one aspect, in the compounds of Formula I, Ia, Ib, II, II.a and II.b, the variable n is 1 and R A It's fluorine.

[0101] In a preferred embodiment, in the compounds of formula I, Ia, Ib, II, II.a and II.b, the variable n is 0.

[0102] A further embodiment relates to the variable R in the compounds of formula I, III, Ia and Ib, IV, V and VI 1 and R 2 meaning.

[0103] One embodiment relates to the preparation of compounds of Formula I, III, Ia and Ib, IV, V and VI, wherein R 1 is methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, cyclopropyl, 2-methoxyiminoethyl, bicyclo[1.1.1]pent-1-yl or phenyl; wherein phenyl is unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different radicals selected from fluorine, chlorine, cyano, methyl, ethyl, methoxy, trifluoromethyl, trifluoromethoxy, difluoromethyl, difluoromethoxy and cyclopropyl; 2 is hydrogen, methyl or ethyl.

[0104] Another embodiment relates to the preparation of compounds of Formula I, III, Ia and Ib, IV, V and VI, wherein R 1 is methyl or phenyl, wherein the phenyl ring is unsubstituted or substituted by 1, 2, 3 or 4 identical or different groups selected from halogen; wherein R 2 is hydrogen, methyl or ethyl.

[0105] Further embodiments relate to the preparation of compounds of Formula I, III, Ia and Ib, IV, V and VI, wherein R 1 is methyl, 2-methoxyiminoethyl, bicyclo[1.1.1]pent-1-yl, 2-fluorophenyl, 4-fluorophenyl or 2-difluoromethoxy-phenyl; R 2 It's hydrogen.

[0106] Yet another embodiment relates to the preparation of compounds of Formula I, III, Ia and Ib, IV, V and VI, wherein R 1 is methyl, 2-fluorophenyl, 4-fluorophenyl or 2,4-difluoro-phenyl; in particular methyl or 2-fluorophenyl; wherein R 2 It's hydrogen.

[0107] In a preferred embodiment of the present invention (Embodiment E.1), the carbonylation reaction uses sodium carbonate or potassium carbonate as base b1 in an amount of 90 to 150 mol % based on the amount of the compound of formula II; the base b1 is especially potassium carbonate; and TBD or DBU as base b2 in an amount of 1 to 30 mol % based on the amount of the compound of formula II.

[0108] Embodiment E.2: Based on Embodiment E.1, wherein the carbonylation is carried out at a temperature of 90°C to 140°C and at a carbon monoxide partial pressure of 5 to 15 bar (500 to 1500 kPa).

[0109] Embodiment E.3: Based on Embodiment E.2, the reaction is carried out in the presence of a palladium catalyst in an amount of less than 2 mol% based on the amount of the compound of Formula II; wherein at least one organic monodentate or bidentate phosphine ligand is used for the palladium catalyst, which is selected from triphenylphosphine, tri(tolyl)phosphine, tri-n-butylphosphine, tricyclohexylphosphine, triisopropylphosphine, tri-tert-butylphosphine, S-phos (2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl), cyclohexyldiphenylphosphine, triisopropylphosphine, phenyldicyclohexylphosphine, butyldiadamantylphosphine, 1,2-bis(dimethylphosphino)ethane, 2,2'-bis(diphenyl)phosphine 1,1'-Bis(diphenylphosphino)-1,1'-binaphthyl (BINAP), 2-bis(diphenylphosphino)ethane (DPPE), 1,3-bis(diphenylphosphino)-propane (DPPP), 1,4-bis(diphenylphosphino)butane (DPPB), 1,1'-bis(diphenylphosphino)ferrocene (DPPF), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (Xantphos), bis(2-diphenylphosphino)phenyl]ether (DPEphos), 1,2-bis(di-tert-butylphosphinomethyl)benzene, 1,2-bis(di-tert-amylphosphinomethyl)-benzene, 1,2-bis(di-tert-butylphosphinomethyl) -tert-butylphosphinomethyl)naphthalene, 2,2-dimethyl-1,3-bis(diphenylphosphino)-propane, 1,3-bis(diisopropylphosphino)-propane (DiPrPP), 1,3-bis(tert-butylphosphino)-propane (DtBuPP), 1,3-bis(n-butylphosphino)-propane (DnBuPP), 1,3-bis(diisopropylphosphino)-ethane (DCPE), 1,3-bis(dicyclohexylphosphino)-butane (DCPB), (1R)-1-[bis(1,1-dimethylethyl)phosphino]-2-[(1R)-1-[bis(2-methylphenyl)phosphino]ethyl]diphosphino] Ferrocene, (2R)-1-[(1R)-1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)ferrocene, (2R)-1-[(1R)-1-(dicyclohexylphosphino)ethyl]-2-(diphenylphosphino)ferrocene, (1R)-1-(dicyclohexylphosphino)-2-[(1R)-1-(dicyclohexylphosphino)ethyl]ferrocene, 2-ethyl-2-butyl-1,3-bis(diphenylphosphino)-propane and 1,3-bis(dicyclohexylphosphino)-propane (DCPP); wherein the molar ratio of the phosphine ligand to palladium is between 0.5:1 and 5:1.

[0110] Embodiment E.4: Based on Embodiment E.3, wherein the molar ratio of the compound of Formula III to the compound of Formula II is between 1:1 and 2:1.

[0111] Embodiment E.5: Based on embodiment E.4, wherein the solvent is tetrahydrofuran, dimethylformamide, N-methylpyrrolidone, dioxane, 2-methyltetrahydrofuran, N,N-dimethylacetamide, toluene or acetonitrile.

[0112] Embodiment E.6: Based on Embodiment E.5, wherein the method involves the preparation of compounds of Formula Ib, IV, V and VI, wherein R 1 is methyl or 2-fluorophenyl; wherein R 2 It's hydrogen.

[0113] The compound of formula Ib can be further transformed to obtain the compound of formula IV, wherein the variable R A ,n,R 1 and R 2 As defined or preferably defined herein. Compound IV is useful for the synthesis of 3-aryl-5-trifluoromethyl-1,2,4- Valuable chemical intermediates of oxadiazoles, 3-aryl-5-trifluoromethyl-1,2,4- Oxadiazoles are known to be useful for controlling plant pathogenic fungi.

[0114]

[0115] Accordingly, compounds of formula IV can be obtained by treating compounds of formula Ib with hydroxylamine or a salt thereof, such as the hydrochloride salt, in the presence of a base, preferably triethylamine, sodium hydroxide or sodium methoxide, in a suitable solvent such as methanol, ethanol or water or a mixture of these solvents at a temperature of 0° C. to 100° C. For relevant examples, see Kitamura, S. et al., Chem. Pharm. Bull. 2001, 49, 268 or any of the patent references cited above.

[0116] Typically, the fungicidal 3-aryl-5-trifluoromethyl-1,2,4- The preparation of the oxadiazole involves the reaction of a hydroxyamidine compound of formula IV with an activated derivative of trifluoroacetic acid to form Accordingly, in a further embodiment of the present invention, the compound of formula IV is reacted with an activated species of trifluoroacetic acid to obtain a compound of formula V, wherein the variable R A ,n,R 1 and R 2 As defined or preferably defined herein.

[0117]

[0118] Used to form The procedures for oxadiazoles are described in WO 2017 / 198852, WO 2017 / 207757, WO 2017220485, WO 2018 / 065414, WO 2019 / 020451 and WO 2017 / 211652 A1.

[0119] Another embodiment of the present invention relates to the process further comprising the step of reacting the compound of formula V to obtain the compound of formula VI, wherein the variable R A ,n,R 1 and R 2 As defined or preferably defined herein.

[0120]

[0121] The compound of formula VI can be prepared from the compound of formula V by treating with Lawesson reagent or phosphorus pentasulfide in an inert organic solvent such as non-halogenated aliphatic hydrocarbons, non-halogenated alicyclic hydrocarbons, halogenated aliphatic hydrocarbons, halogenated aromatic hydrocarbons, amides, ethers, esters, ketones, nitriles; for example, toluene, tetrahydrofuran, dioxane or ethyl acetate; at a temperature of 0°C to 130°C, preferably 60°C to 80°C. See, for example, Eur. J. Med. Chem. 2011, 46 (9), 3917-3925; Synthesis 2003, 13, 1929–1958, WO 2006 / 0123242, WO 2010 / 086820, WO 2014 / 0151863, WO 2019 / 020451 and WO 2017 / 211649. After the reaction is completed, the reaction mixture is worked up in a conventional manner.

[0122] In particular, the present invention relates to the preparation of compounds Va, Vb and VI.a.

[0123]

[0124] In the definitions of the variables given above, collective terms are used which generally represent the substituents involved.

[0125] The term "C n -C m ” indicates in each case the possible number of carbon atoms in the substituent or substituent moiety in question.

[0126] The term "halogen" refers to fluorine, chlorine, bromine and iodine.

[0127] The term "oxo" refers to an oxygen atom =0, which is bonded to a carbon atom or a sulfur atom, thereby forming, for example, a keto group -C(=O)- or a sulfinyl group -S(=O)-.

[0128] The term "formyl" refers to the group C(=O)H.

[0129] The term "C1-C6-alkyl" refers to a straight-chain or branched saturated hydrocarbon radical having 1 to 6 carbon atoms, for example methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl and 1,1-dimethylethyl.

[0130] The term "C2-C6-alkenyl" refers to a straight-chain or branched unsaturated hydrocarbon group having 2 to 6 carbon atoms and a double bond at any position, such as ethenyl, 1-propenyl, 2-propenyl (allyl), 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl.

[0131] The term "C2-C6-alkynyl" refers to a straight-chain or branched unsaturated hydrocarbon group having 2 to 6 carbon atoms and containing at least one triple bond, such as ethynyl, 1-propynyl, 2-propynyl (propargyl), 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl.

[0132] The term "C1-C6-haloalkyl" refers to straight-chain or branched alkyl groups (as defined above) having 1 to 6 carbon atoms, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as mentioned above, for example chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2 -fluoroethyl, 2,2,2-trichloroethyl and pentafluoroethyl, 2-fluoropropyl, 3-fluoropropyl, 2,2-difluoropropyl, 2,3-difluoropropyl, 2-chloropropyl, 3-chloropropyl, 2,3-dichloropropyl, 2-bromopropyl, 3-bromopropyl, 3,3,3-trifluoropropyl, 3,3,3-trichloropropyl, CH2-C2F5, CF2-C2F5, CF(CF3)2, 1-(fluoromethyl)-2-fluoroethyl, 1-(chloromethyl)-2-chloroethyl, 1-(bromomethyl)-2-bromoethyl, 4-fluorobutyl, 4-chlorobutyl, 4-bromobutyl or nonafluorobutyl.

[0133] The term "C1-C6-alkoxy" refers to a straight-chain or branched alkyl group having 1 to 6 carbon atoms (as defined above) bonded via an oxygen in any position of the alkyl group, for example methoxy, ethoxy, n-propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy or 1,1-dimethylethoxy.

[0134] The term "C1-C6-haloalkoxy" refers to a C1-C6-alkoxy group as defined above in which some or all of the hydrogen atoms may be replaced by halogen atoms as mentioned above, for example OCH2F, OCHF2, OCF3, OCH2Cl, OCHCl2, OCCl3, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2- ... , 2-trichloroethoxy, OC2F5, 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-difluoropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH2-C2F5, OCF2-C2F5, 1-(CH2F)-2-fluoroethoxy, 1-(CH2Cl)-2-chloroethoxy, 1-(CH2Br)-2-bromoethoxy, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy.

[0135] The term "phenyl-C1-C4-alkyl or heteroaryl-C1-C4-alkyl" refers to an alkyl group having 1 to 4 carbon atoms (as defined above) wherein one of the hydrogen atoms of the alkyl group is replaced by a phenyl or heteroaryl group, respectively.

[0136] The term "C1-C4-alkoxy-C1-C4-alkyl" refers to an alkyl group (as defined above) having 1 to 4 carbon atoms in which one of the hydrogen atoms of the alkyl group is replaced by a C1-C4-alkoxy group (as defined above). Similarly, the term "C1-C4-alkylthio-C1-C4-alkyl" refers to an alkyl group (as defined above) having 1 to 4 carbon atoms in which one of the hydrogen atoms of the alkyl group is replaced by a C1-C4-alkylthio group.

[0137] The term "C1-C6-alkylthio" as used herein refers to a straight-chain or branched alkyl group (as defined above) having 1 to 6 carbon atoms bonded via a sulfur atom. Accordingly, the term "C1-C6-haloalkylthio" as used herein refers to a straight-chain or branched haloalkyl group (as defined above) having 1 to 6 carbon atoms bonded via a sulfur atom at any position in the haloalkyl group.

[0138] The term "C1-C4-alkoxyimino" refers to a divalent imino group (C1-C4-alkyl-ON=) having a C1-C4-alkoxy group as a substituent, for example, methylimino, ethylimino, propylimino, 1-methylethylimino, butylimino, 1-methylpropylimino, 2-methylpropylimino, 1,1-dimethylethylimino, and the like.

[0139] The term "C1-C6-alkoxyimino-C1-C4-alkyl" refers to an alkyl group having 1 to 4 carbon atoms in which two hydrogen atoms of one carbon atom of the alkyl group are replaced by a divalent C1-C6-alkoxyimino group (C1-C6-alkyl-ON=) as defined above.

[0140] The term "C2-C6-alkenyloxyimino-C1-C4-alkyl" refers to an alkyl group having 1 to 4 carbon atoms in which two hydrogen atoms of one carbon atom of the alkyl group are replaced by a divalent C2-C6-alkenyloxyimino group (C2-C6-alkenyl-ON=).

[0141] The term "C2-C6-alkynyloxyimino-C1-C4-alkyl" refers to an alkyl group having 1 to 4 carbon atoms in which two hydrogen atoms of one carbon atom of the alkyl group are replaced by a divalent C2-C6-alkynyloxyimino group (C2-C6-alkynyl-ON=).

[0142] The term "hydroxy C1-C4-alkyl" refers to an alkyl group having 1 to 4 carbon atoms in which one of the hydrogen atoms of the alkyl group is replaced by an OH group.

[0143] The term "amino C1-C4-alkyl" refers to an alkyl group having 1 to 4 carbon atoms wherein one of the hydrogen atoms of the alkyl group is replaced by an NH2 group.

[0144] The term "C1-C6-alkylamino" refers to an amino group substituted by one residue independently selected from the group defined by the term C1-C6-alkyl. Similarly, the term "di-C1-C6-alkylamino" refers to an amino group substituted by two residues independently selected from the group defined by the term C1-C6-alkyl.

[0145] The term "C1-C4-alkylamino-C1-C4-alkyl" refers to an alkyl group having 1 to 4 carbon atoms (as defined above) in which one of the hydrogen atoms of the alkyl group is replaced by a C1-C4-alkyl-NH-group bonded via nitrogen. Similarly, the term "di-C1-C4-alkylamino-C1-C4-alkyl" refers to an alkyl group having 1 to 4 carbon atoms (as defined above) in which one of the hydrogen atoms of the alkyl group is replaced by a (C1-C4-alkyl)2N-group bonded via nitrogen.

[0146] The term "aminocarbonyl-C1-C4-alkyl" refers to an alkyl group having 1 to 4 carbon atoms wherein one of the hydrogen atoms of the alkyl group is replaced by a -(C=O)-NH2 group.

[0147] The term "C2-C6-alkenyl" refers to a straight-chain or branched unsaturated hydrocarbon group having 2 to 6 carbon atoms and a double bond at any position, such as ethenyl, 1-propenyl, 2-propenyl (allyl), 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl.

[0148] The term "C2-C6-alkynyl" refers to a straight-chain or branched unsaturated hydrocarbon group having 2 to 6 carbon atoms and containing at least one triple bond, such as ethynyl, 1-propynyl, 2-propynyl (propargyl), 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl.

[0149] The term "C3-C 11 "-cycloalkyl" refers to a monocyclic, bicyclic or tricyclic saturated monovalent hydrocarbon radical having 3 to 11 carbon ring members attached via one of the ring carbon atoms by replacing one hydrogen atom, such as cyclopropyl (C3H5), cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, bicyclo[1.1.0]butyl, bicyclo[2.1.0]pentyl, bicyclo[1.1.1]pentyl, bicyclo[3.1.0]hexyl, bicyclo[2.1.1]hexyl, norcaranyl (bicyclo[4.1.0]heptyl) and norbornyl (bicyclo[2.2.1]heptyl). Further examples of bicyclic or tricyclic cycloalkyl radicals are provided herein as examples R 1 .1 to R 1 .57.

[0150] The term "C3-C 11 "-Cycloalkyl" refers to a monocyclic, bicyclic or tricyclic saturated monovalent hydrocarbon radical having 3 to 11 carbon ring members attached via one of the ring carbon atoms by replacing one hydrogen atom, such as cyclopropyl (C3H5), cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, bicyclo[1.1.0]butyl, bicyclo[2.1.0]pentyl, bicyclo[1.1.1]pentyl, bicyclo[3.1.0]hexyl, bicyclo[2.1.1]hexyl, norcaranyl (bicyclo[4.1.0]heptyl) and norbornyl (bicyclo[2.2.1]heptyl).

[0151] The term "C3-C 11 "-cycloalkyl-C1-C6-alkyl" means a C3-C6-alkyl group in which one of the hydrogen atoms of the alkyl group is replaced by a C3-C6-alkyl group as defined above 11 - a cycloalkyl-substituted alkyl group having 1 to 11 carbon atoms.

[0152] The term "C3-C 11"-Cycloalkoxy" means a cyclic monovalent hydrocarbon radical (as defined above) having 3 to 11 carbon ring members bonded via the oxygen at any position of the cycloalkyl radical, for example cyclopropyloxy.

[0153] The terms "-C(=O)-C1-C4-alkyl", "-C(=O)-O-C1-C4-alkyl" and "-C(=O)-C3-C 11 "-Cycloalkyl" refers to a group attached via a carbon atom of a -C(=O)- group.

[0154] The term "aliphatic" refers to compounds or groups that are composed of carbon and hydrogen and are non-aromatic compounds. "Alicyclic" compounds or groups are organic compounds that are both aliphatic and cyclic. They contain one or more all-carbon rings that may be saturated or unsaturated but do not have aromatic character.

[0155] The term "cyclic moiety" or "cyclic group" refers to a group that is an alicyclic ring or an aromatic ring, such as phenyl or heteroaryl.

[0156] The term "wherein any aliphatic or cyclic group is unsubstituted or substituted..." refers to aliphatic groups, cyclic groups and groups containing aliphatic and cyclic moieties in one group, such as in, for example, C3-C8-cycloalkyl-C1-C4-alkyl; thus, groups containing aliphatic and cyclic moieties - these moieties can be substituted or unsubstituted independently of each other.

[0157] The term "phenyl" refers to an aromatic ring system (commonly referred to as a benzene ring) comprising 6 carbon atoms.

[0158] The term "heteroaryl" refers to an aromatic monocyclic or multicyclic ring system which includes 1, 2, 3 or 4 heteroatoms independently selected from N, O and S in addition to carbon atoms.

[0159] The term "saturated 3- to 7-membered carbocycle" is understood to mean a monocyclic saturated carbocycle having 3, 4 or 5 carbon ring members. Examples include cyclopropyl, cyclopentyl, cyclohexyl, cycloheptyl and the like.

[0160] The term "3- to 10-membered saturated, partially unsaturated or aromatic monocyclic or bicyclic heterocycle, wherein the ring member atoms of the monocyclic or bicyclic heterocycle include, besides carbon atoms, further 1, 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms" is understood to mean aromatic monocyclic and bicyclic heteroaromatic ring systems, and saturated and partially unsaturated heterocycles, for example:

[0161] 3- or 4-membered saturated heterocycles containing 1 or 2 heteroatoms selected from N, O and S as ring members, such as oxirane, aziridine, thiirane, oxetane, azetidine, thiethane, [1,2]dioxetane, [1,2]dithietane, [1,2]diazetidine;

[0162] and a 5- or 6-membered saturated or partially unsaturated heterocyclic ring containing 1, 2 or 3 heteroatoms selected from N, O and S as ring members, such as 2-tetrahydrofuranyl, 3-tetrahydrofuranyl, 2-tetrahydrothienyl, 3-tetrahydrothienyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 3-isothiophene, Oxazolidinyl, 4-iso Oxazolidinyl, 5-iso oxazolidinyl, 3-isothiazolidinyl, 4-isothiazolidinyl, 5-isothiazolidinyl, 3-pyrazolidinyl, 4-pyrazolidinyl, 5-pyrazolidinyl, 2- Oxazolidinyl, 4- Oxazolidinyl, 5- oxazolidinyl, 2-thiazolidinyl, 4-thiazolidinyl, 5-thiazolidinyl, 2-imidazolidinyl, 4-imidazolidinyl, 1,2,4- oxadiazolidine-3-yl, 1,2,4- 1,2,4-thiadiazolidin-5-yl, 1,2,4-thiadiazolidin-3-yl, 1,2,4-thiadiazolidin-5-yl, 1,2,4-triazolidin-3-yl, 1,3,4- oxadiazolidin-2-yl, 1,3,4-thiadiazolidin-2-yl, 1,3,4-triazolidin-2-yl, 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,4-dihydrofuran-2-yl, 2,4-dihydrofuran-3-yl, 2,3-dihydrothiophen-2-yl, 2,3-dihydrothiophen-3-yl, 2,4-dihydrothiophen-2-yl, 2,4-dihydrothiophen-3-yl, 2-pyrrolidine-2-yl, 2-pyrrolidine-3-yl, 3-pyrrolidine-2-yl, 3-pyrrolidine-3-yl, 2-isothiophene-2-yl, 2-isothiophene ...3-yl, 2-isothiophene-2-yl, 2-isothiophene-3-yl, 2-isothiophene-3-yl, 2-isothiophene-3-yl, 2-isothiophene-2-yl, 2- Oxazoline-3-yl, 3-iso Oxazoline-3-yl, 4-iso Oxazoline-3-yl, 2-iso Oxazoline-4-yl, 3-iso Oxazolin-4-yl, 4-iso Oxazoline-4-yl, 2-iso Oxazoline-5-yl, 3-iso Oxazoline-5-yl, 4-iso oxazolin-5-yl, 2-isothiazolin-3-yl, 3-isothiazolin-3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin-4-yl, 4-isothiazolin-4-yl, 2-isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3-dihydropyrazol-1-yl, 2,3-dihydropyrazol-2-yl, 2,3-dihydropyrazol- -3-yl, 2,3-dihydropyrazol-4-yl, 2,3-dihydropyrazol-5-yl, 3,4-dihydropyrazol-1-yl, 3,4-dihydropyrazol-3-yl, 3,4-dihydropyrazol-4-yl, 3,4-dihydropyrazol-5-yl, 4,5-dihydropyrazol-1-yl, 4,5-dihydropyrazol-3-yl, 4,5-dihydropyrazol-4-yl, 4,5-dihydropyrazol-5 ...2,3-dihydropyrazol-5-yl, 2,3-dihydropyrazol-5-yl, 2,3-dihydropyrazol-3-yl, 3,4-dihydropyrazol-4-yl, 3,4-dihydropyrazol-5-yl, 4,5-dihydropyrazol-1-yl, 4,5-dihydropyrazol-3-yl, 4,5-dihydropyrazol-4-yl, 4,5-dihydropyrazol-5-yl, 2,3-dihydropyrazol-5-yl, 2,3-dihydropyrazol-5-yl, 2,3-dihydropyrazol- Oxazol-2-yl, 2,3-dihydro Oxazol-3-yl, 2,3-dihydro Oxazol-4-yl, 2,3-dihydro Oxazol-5-yl, 3,4-dihydro Oxazol-2-yl, 3,4-dihydro Oxazol-3-yl, 3,4-dihydro Oxazol-4-yl, 3,4-dihydro Oxazol-5-yl, 3,4-dihydro Oxazol-2-yl, 3,4-dihydro Oxazol-3-yl, 3,4-dihydro oxazol-4-yl, 2-piperidinyl, 3-piperidinyl, 4-piperidinyl, 1,3-dioxan-5-yl, 2-tetrahydropyranyl, 4-tetrahydropyranyl, 2-tetrahydrothienyl, 3-hexahydropyridazinyl, 4-hexahydropyridazinyl, 2-hexahydropyrimidinyl, 4-hexahydropyrimidinyl, 5-hexahydropyrimidinyl, 2-piperazinyl, 1,3,5-hexahydrotriazin-2-yl and 1,2,4-hexahydrotriazin-3-yl and the corresponding -subunits; and 7-membered saturated or partially unsaturated heterocycles, such as tetrahydro- and hexahydroazepines 2,3,4,5-tetrahydro[1H]azepine -1-, -2-, -3-, -4-, -5-, -6- or -7-yl, 3,4,5,6-tetrahydro[2H]azepine -2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,4,7-tetrahydro[1H]azepine -1-, -2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7-tetrahydro[1H]azepine -1-, -2-, -3-, -4-, -5-, -6- or -7-yl, hexahydroazepine -1-, -2-, -3- or -4-yl, tetrahydro- and hexahydrooxepinyl, such as 2,3,4,5-tetrahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,4,7-tetrahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7-tetrahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, hexahydroazepine -1-, -2-, -3- or -4-yl, tetrahydro- and hexahydro-1,3-diazepines 1,4-diazepine, tetrahydro- and hexahydro-1,4-diazepine 1,3-oxazepine Oxazepinyl, tetrahydro- and hexahydro-1,4-oxazepinyl 1,4-dioxepinyl, tetrahydro- and hexahydro-1,3-dioxepinyl, tetrahydro- and hexahydro-1,4-dioxepinyl and the corresponding -ylidenes.

[0163] The term "5- or 6-membered heteroaryl" or the term "5- or 6-membered aromatic heterocycle" refers to an aromatic ring system which, in addition to carbon atoms, comprises 1, 2, 3 or 4 heteroatoms independently selected from N, O and S, for example a 5-membered heteroaryl such as pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thiophen-2-yl, thiophen-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, Oxazol-2-yl, Oxazol-4-yl, oxazol-5-yl, isoxazol-5-yl Oxazol-3-yl, iso Oxazol-4-yl, iso oxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,2,4-triazol-1-yl, 1,2,4-triazol-3-yl, 1,2,4-triazol-5-yl, 1,2,4- oxadiazole-3-yl, 1,2,4- or 6-membered heteroaryl, such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1,3,5-triazin-2-yl and 1,2,4-triazin-3-yl.

[0164] Operation Example

[0165] The present invention is further illustrated by means of the following working examples.

[0166] Example 1) Preparation of 4-cyano-N-(2-fluorophenyl)-benzamide (not according to the present invention)

[0167] Palladium (II) chloride (3.8 mg, 0.021 mmol), 1,3-bis (dicyclohexylphosphino) propane bis (tetrafluoroborate) (DCPP * HBF4, 12.9 mg, 0.021 mmol), potassium carbonate (1.12 g, 8.1 mmol) and 4-chlorobenzonitrile (1.12 g, 8.1 mmol) were kept under argon in an autoclave. 2-Fluoroaniline (1.74 g, 15.7 mmol) and tetrahydrofuran (10 ml) were added under argon and carbon monoxide was introduced into the reaction vessel under a pressure of 10 bar (1000 kPa). The reaction mixture was stirred at 130 ° C for 20 hours (stirring rate 1000 rpm). Then, the reaction mixture was cooled to room temperature and the pressure was released.

[0168] GC conversion*: 45%; selectivity to carboxamide: 95%.

[0169] Unless otherwise indicated, Examples 2, 3, 1.1 to 1.6 of Table 1 below each reproduce the same reaction conditions as the above-described Example 1. Examples 1.1 to 1.6 represent variations according to the invention since they comprise, in addition to a stoichiometric amount of a base of type b1, a catalytic amount of DBU, based on the amount of 4-chlorobenzonitrile.

[0170] It was observed that at low catalyst concentrations, the reaction eventually stopped and the desired conversion was not achieved (Example 1, the catalyst composition gave a conversion of 45% after a reaction time of 20 hours). If the reaction time was extended to 40 hours, a conversion of 72% was observed under these conditions (Example 2). Example 3 shows that an equimolar amount of DBU based on the amount of 4-chlorobenzonitrile did not lead to an increase in conversion after 20 hours in the absence of a base of type b1.

[0171] Surprisingly, it was found that after adding a catalytic amount of base b2 (DBU, 5 mol %), significantly higher conversions were achieved (Examples 1.1 and 1.2). Example 1.2 shows that extending the reaction time to 40 hours gives 88% conversion compared to 72% conversion in Example 2. Examples 1.3 to 1.5 show that different Pd and ligand sources can be used successfully. Example 1.6 shows that potassium carbonate (base b1) can be replaced by another base.

[0172] Table 1:

[0173]

[0174] a) Same as above-mentioned embodiment 1;

[0175] b) Embodiments not according to the present invention;

[0176] c) Representing embodiments of the present invention;

[0177] d) Pd(10%) / carbon, mol% refers to the molar amount of Pd;

[0178] e) There is no potassium carbonate present;

[0179] f) Use sodium carbonate instead of potassium carbonate;

[0180] *Analytical GC method: VF-23 column (60m x 0.25mm / 0.25μm; temperature: 2min at 50°C, then 10°C / min to 100°C; then 15°C / min to 200°C; 5min at 200°C; then 20°C / min to 250°C; flow rate: 2.0mL / min; hydrogen as carrier gas). R (2-fluoroaniline) = 10.9 min; t R (4-chlorobenzonitrile) = 12.5 min; t R (carboxamide) = 34.3 min.

Claims

1. A method for preparing an aromatic carboxamide of formula Ib, in n is 0 or 1; R A R is independently selected from fluorine, chlorine, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, -S(=O)2-CH3, -OC≡N, -SC≡N, -N=C=O, -N=C=S, di-C1-C6-alkylamino, -C(=O)-C1-C6-alkyl, -C(=O)-O-C1-C6-alkyl and -CH2OH; 1 is methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, cyclopropyl, 2-methoxyiminoethyl, bicyclo[1.1.1]pent-1-yl or phenyl; wherein phenyl is unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different radicals selected from halogen, cyano, methyl, ethyl, methoxy, trifluoromethyl, trifluoromethoxy, difluoromethyl, difluoromethoxy and cyclopropyl; and R 2 is hydrogen, methyl or ethyl; The method comprises reacting an aromatic chloride of formula II.b with carbon monoxide and an amine compound of formula III where variables n and R A As defined above for compounds of formula Ib, Where R 1 and R 2 As defined above for compounds of formula Ib; The reaction is carried out in the presence of a palladium-based catalyst, a solvent and a base; The method is characterized in that the base comprises base b1 and base b2, wherein Base b1 is an alkali metal carbonate or an alkali metal acetate; Base b2 is 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), 1,5-diazabicyclo[4.3.0]non-5-ene (DBN) or 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD), which is present in an amount of less than 100 mol %, based on the amount of compound of formula II.b.

2. The method according to claim 1, wherein n is 0.

3. The method according to claim 1, wherein in the compounds of formula Ib and III, R 1is methyl or phenyl, wherein the phenyl ring is unsubstituted or substituted by 1, 2, 3 or 4 identical or different groups selected from halogen; wherein R 2 is hydrogen, methyl or ethyl.

4. The method according to claim 2, wherein in the compounds of formula Ib and III, R 1 is methyl or phenyl, wherein the phenyl ring is unsubstituted or substituted by 1, 2, 3 or 4 identical or different groups selected from halogen; wherein R 2 is hydrogen, methyl or ethyl.

5. The method according to claim 1, wherein in the compounds of formula Ib and III, R 1 is methyl or 2-fluorophenyl; wherein R 2 It's hydrogen.

6. The method according to claim 2, wherein in the compounds of formula Ib and III, R 1 is methyl or 2-fluorophenyl; wherein R 2 It's hydrogen.

7. The method according to claim 3, wherein in the compounds of formula Ib and III, R 1 is methyl or 2-fluorophenyl; wherein R 2 It's hydrogen.

8. The method according to claim 4, wherein in the compounds of formula Ib and III, R 1 is methyl or 2-fluorophenyl; wherein R 2 It's hydrogen.

9. The process according to claim 1, wherein the base b1 is used in an amount of 90 to 150 mol %, based on the aromatic chloride of the formula II.b.

10. The process according to claim 1, wherein the base b2 is used in an amount of 1 to 20 mol %, based on the aromatic chloride of the formula II.b.

11. The process according to claim 9, wherein the base b2 is used in an amount of 1 to 20 mol %, based on the aromatic chloride of the formula II.b.

12. The process according to any one of claims 1 to 8, wherein the process is carried out at a temperature of 50°C to 150°C.

13. The process according to claim 11, wherein the process is carried out at a temperature of 50°C to 150°C.

14. The process according to any one of claims 1 to 8, wherein the process is carried out at a pressure of 500 to 1500 kPa.

15. The process according to claim 13, wherein the process is carried out at a pressure of 500 to 1500 kPa.

16. The process according to any one of claims 1 to 8, wherein the palladium-based catalyst is prepared from a Pd(II) compound or a Pd(0) compound by complexing with a monodentate or bidentate phosphine ligand.

17. The method according to claim 15, wherein the palladium-based catalyst is prepared from a Pd(II) compound or a Pd(0) compound by complexing with a monodentate or bidentate phosphine ligand.

18. The method according to any one of claims 1 to 8, wherein the palladium-based catalyst is prepared by complexing a Pd(II) compound or a Pd(O) compound with a monodentate or bidentate phosphine ligand selected from triphenylphosphine, tri(tolyl)phosphine, tri-n-butylphosphine, tricyclohexylphosphine, tri-tert-butylphosphine, S-phos(2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl), cyclohexyldiphenylphosphine, triisopropylphosphine, phenyldicyclohexylphosphine, butyldiadamantylphosphine, 1,2-bis(dimethylphosphino)ethane, 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl(B-phospho)ethane, INAP), 2-bis(diphenylphosphino)ethane (DPPE), 1,3-bis(diphenylphosphino)-propane (DPPP), 1,4-bis(diphenylphosphino)butane (DPPB), 1,1'-bis(diphenylphosphino)ferrocene (DPPF), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (Xantphos), bis(2-diphenylphosphino)phenyl]ether (DPEphos), 1,2-bis(di-tert-butylphosphinomethyl)benzene, 1,2-bis(di-tert-amylphosphinomethyl)benzene, 1,2-bis(di-tert-butylphosphinomethyl)naphthalene , 2,2-dimethyl-1,3-bis(diphenylphosphino)-propane, 1,3-bis(diisopropylphosphino)-propane (DiPrPP), 1,3-bis(tert-butylphosphino)-propane (DtBuPP), 1,3-bis(n-butylphosphino)-propane (DnBuPP), 1,3-bis(diisopropylphosphino)-ethane (DCPE), 1,3-bis(dicyclohexylphosphino)-butane (DCPB), (1R)-1-[bis(1,1-dimethylethyl)phosphino]-2-[(1R)-1-[bis(2-methylphenyl)phosphino]ethyl]ferrocene, (2 R)-1-[(1R)-1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)ferrocene, (2R)-1-[(1R)-1-(dicyclohexylphosphino)ethyl]-2-(diphenylphosphino)ferrocene, (1R)-1-(dicyclohexylphosphino)-2-[(1R)-1-(dicyclohexylphosphino)ethyl]ferrocene, 2-ethyl-2-butyl-1,3-bis(diphenylphosphino)-propane and 1,3-bis(dicyclohexylphosphino)-propane (DCPP); wherein the molar ratio of the phosphine ligand to palladium is between 0.5:1 and 5:

1.

19. The method according to claim 15, wherein the palladium-based catalyst is prepared by complexing a Pd(II) compound or a Pd(O) compound with a monodentate or bidentate phosphine ligand selected from triphenylphosphine, tri(tolyl)phosphine, tri-n-butylphosphine, tricyclohexylphosphine, tri-tert-butylphosphine, S-phos(2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl), cyclohexyldiphenylphosphine, triisopropylphosphine, phenyldicyclohexylphosphine, butyldiadamantylphosphine, 1,2-bis(dimethylphosphino)ethane, 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (BINA P), 2-bis(diphenylphosphino)ethane (DPPE), 1,3-bis(diphenylphosphino)-propane (DPPP), 1,4-bis(diphenylphosphino)butane (DPPB), 1,1'-bis(diphenylphosphino)ferrocene (DPPF), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (Xantphos), bis(2-diphenylphosphino)phenyl]ether (DPEphos), 1,2-bis(di-tert-butylphosphinomethyl)benzene, 1,2-bis(di-tert-amylphosphinomethyl)benzene, 1,2-bis(di-tert-butylphosphinomethyl)naphthalene, 2 ,2-dimethyl-1,3-bis(diphenylphosphino)-propane, 1,3-bis(diisopropylphosphino)-propane (DiPrPP), 1,3-bis(tert-butylphosphino)-propane (DtBuPP), 1,3-bis(n-butylphosphino)-propane (DnBuPP), 1,3-bis(diisopropylphosphino)-ethane (DCPE), 1,3-bis(dicyclohexylphosphino)-butane (DCPB), (1R)-1-[bis(1,1-dimethylethyl)phosphino]-2-[(1R)-1-[bis(2-methylphenyl)phosphino]ethyl]ferrocene, (2R )-1-[(1R)-1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)ferrocene, (2R)-1-[(1R)-1-(dicyclohexylphosphino)ethyl]-2-(diphenylphosphino)ferrocene, (1R)-1-(dicyclohexylphosphino)-2-[(1R)-1-(dicyclohexylphosphino)ethyl]ferrocene, 2-ethyl-2-butyl-1,3-bis(diphenylphosphino)-propane and 1,3-bis(dicyclohexylphosphino)-propane (DCPP); wherein the molar ratio of the phosphine ligand to palladium is between 0.5:1 and 5:

1.

20. The process according to any one of claims 1 to 8, further comprising the step of reacting the compound of formula Ib with hydroxylamine or a salt thereof to obtain a compound of formula IV 21. The method according to claim 19, further comprising the step of reacting the compound of formula Ib with hydroxylamine or a salt thereof to obtain a compound of formula IV 22. The method according to claim 20, further comprising the step of reacting the compound of formula IV to obtain the compound of formula V 23. The method according to claim 21, further comprising the step of reacting the compound of formula IV to obtain the compound of formula V 24. The method according to claim 22, further comprising the step of reacting the compound of formula V with Lawesson's reagent or phosphorus pentasulfide to obtain the compound of formula VI 25. The method according to claim 23, further comprising the step of reacting the compound of formula V with Lawesson's reagent or phosphorus pentasulfide to obtain a compound of formula VI

Citation Information

Patent Citations

  • Process for the preparation of carboxylic acid esters from organic halides

    US3988358A

  • Process for the preparation of carboxylic acid amides from organic halides

    US4128554A

  • Preparation of aromatic amides from carbon monoxide, an amine and an aromatic chloride

    US5672750A

  • 1, 2, 4 -triazole derivatives as vasopressin antagonists

    WO2006123242A1

  • Method for producing aromatic and heteroaromatic carboxylic acids, carboxylic acid esters and carboxylic acid amides

    WO2009144197A1